Trial of Taselisib in Overgrowth

NCT03290092 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
19
Enrollment
OTHER
Sponsor class

Stopped In accordance with the protocol, following the occurrence of two SUSARs, the TOTEM trial was stopped early for safety reasons.

Conditions

Interventions

Sponsor

Centre Hospitalier Universitaire Dijon